Clinical Trials
5 trialsNCT04642937 2023-01-27
Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
OX2 Therapeutics
Phase 1 Unknown
NCT05679687 2023-01-11
ThisCART19A Bridging to alloHSCT for R/R B-ALL
The First Affiliated Hospital of Soochow University
Phase 1 Unknown
NCT05673538 2023-01-10
TT-00973-MS Tablets in Patients With Advanced Solid Tumors
TransThera Sciences (Nanjing), Inc.
Phase 1 Unknown
NCT04423380 2020-06-09
A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid Tumors
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 1 Unknown
NCT03767725 2018-12-10
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma
Shenzhen Second People's Hospital
Phase 1 Unknown